CLINICAL_TRIALS
trial_result
· 2016-02-22
Clinical Trial Update: Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer [Phase 2]
Summary
An exploratory Phase 2 study of QBKPN SSI in non-small cell lung cancer has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qu Biologics Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED